<DOC>
	<DOC>NCT02906488</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of long-term use of Duodopa in patients with Parkinson's disease in actual usage</brief_summary>
	<brief_title>Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa, levodopa drug combination</mesh_term>
	<criteria>1. Patients with Parkinson's disease using Duodopa for the purpose of improving circadian change (wearingoff phenomenon) of symptoms of Parkinson's disease in which sufficient effect cannot be obtained with existing drug therapy including levodopacontaining drugs.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Quality of life</keyword>
</DOC>